AU2002332724A1 - Genetic construct intracellular monitoring system - Google Patents

Genetic construct intracellular monitoring system

Info

Publication number
AU2002332724A1
AU2002332724A1 AU2002332724A AU2002332724A AU2002332724A1 AU 2002332724 A1 AU2002332724 A1 AU 2002332724A1 AU 2002332724 A AU2002332724 A AU 2002332724A AU 2002332724 A AU2002332724 A AU 2002332724A AU 2002332724 A1 AU2002332724 A1 AU 2002332724A1
Authority
AU
Australia
Prior art keywords
monitoring system
genetic construct
intracellular monitoring
construct intracellular
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002332724A
Other languages
English (en)
Inventor
Richard Eglen
Inna Vainshtein
Sharon Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DiscoveRx Corp
Original Assignee
DiscoveRx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DiscoveRx Corp filed Critical DiscoveRx Corp
Publication of AU2002332724A1 publication Critical patent/AU2002332724A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002332724A 2001-08-30 2002-08-27 Genetic construct intracellular monitoring system Abandoned AU2002332724A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US31642801P 2001-08-30 2001-08-30
US60/316,428 2001-08-30
US34315601P 2001-10-21 2001-10-21
US60/343,156 2001-10-22
US35308602P 2002-01-30 2002-01-30
US60/353,086 2002-01-30
PCT/US2002/027497 WO2003021265A1 (en) 2001-08-30 2002-08-27 Genetic construct intracellular monitoring system

Publications (1)

Publication Number Publication Date
AU2002332724A1 true AU2002332724A1 (en) 2003-03-18

Family

ID=27405870

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002332724A Abandoned AU2002332724A1 (en) 2001-08-30 2002-08-27 Genetic construct intracellular monitoring system

Country Status (6)

Country Link
US (1) US7479377B2 (https=)
EP (1) EP1421385B1 (https=)
JP (1) JP5580505B2 (https=)
AU (1) AU2002332724A1 (https=)
CA (1) CA2458879C (https=)
WO (1) WO2003021265A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1582332A (zh) * 2001-12-29 2005-02-16 Seoul大学校产学协力财团 转染gfp的克隆猪、敲除gt的克隆猪及其生产方法
EP1556682B8 (en) * 2002-10-21 2010-02-17 DiscoveRx Corporation Ip3 protein binding assay
JP2007521021A (ja) * 2003-11-06 2007-08-02 ディスカヴァーエックス インコーポレイテッド 細胞膜タンパク質の検定
US8586294B2 (en) * 2004-05-18 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
JP4796059B2 (ja) 2004-06-30 2011-10-19 ディスカヴァーエックス コーポレイション 細胞内修飾の分析
WO2007002200A2 (en) * 2005-06-21 2007-01-04 Discoverx, Inc. Mitotic index assay
WO2009043953A1 (es) * 2007-10-05 2009-04-09 Proyecto De Biomedicina Cima, S.L. Empleo de inhibidores de ppar alfa truncado en el tratamiento de la insuficiencia cardiaca en sujetos con cardiopatía hipertensiva
US8865421B2 (en) * 2008-07-02 2014-10-21 Discoverx Corporation Assays for nuclear hormone receptor binding
US20100120063A1 (en) * 2008-10-10 2010-05-13 Discoverx Corporation GPCR Arrestin Assays
US8211655B2 (en) * 2009-02-12 2012-07-03 Discoverx Corporation Wild-type receptor assays
GB0905419D0 (en) 2009-03-30 2009-05-13 Ge Healthcare Uk Ltd Methods for testing ligand binding to G protein-coupled receptors
GB0917877D0 (en) 2009-10-13 2009-11-25 Ge Healthcare Uk Ltd Enzyme fragment complementation assays for monitoring the activiation of the voltage-gated potassium ion channel herg
WO2013119579A1 (en) * 2012-02-06 2013-08-15 Discoveryx Corporation Detection of intracellular binding events by measuring protein abundance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604091A (en) * 1984-03-01 1997-02-18 Microgenics Corporation Methods for protein binding enzyme complementation
US4708929A (en) * 1984-10-29 1987-11-24 Microgenics Corporation Methods for protein binding enzyme complementation assays
DE69731960T2 (de) * 1996-09-24 2005-12-15 Cadus Pharmaceutical Corp. Verfahren und zusammensetzungen für die identifizierung von receptor effectoren
US6037133A (en) * 1998-04-17 2000-03-14 Clontech Laboratories, Inc. IκBEGFP constructs, cell lines and methods of use

Also Published As

Publication number Publication date
CA2458879C (en) 2015-04-28
JP5580505B2 (ja) 2014-08-27
EP1421385A4 (en) 2004-12-01
WO2003021265A1 (en) 2003-03-13
WO2003021265A8 (en) 2004-07-01
US7479377B2 (en) 2009-01-20
JP2005501548A (ja) 2005-01-20
EP1421385B1 (en) 2016-06-29
CA2458879A1 (en) 2003-03-13
US20030092070A1 (en) 2003-05-15
EP1421385A1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
AU2002326933A1 (en) Plasmatron-catalyst system
AU2002351414A1 (en) Backpack system
AU2002364006A1 (en) Micro-rotocraft surveillance system
AU2002342177A1 (en) Battery system
AU2002345340A1 (en) Magneto-massage system
AU2002332724A1 (en) Genetic construct intracellular monitoring system
AUPR875101A0 (en) Monitoring system
AU2002219357A1 (en) Monitoring system
AU2002351380A1 (en) Bookview system
AU2002331951A1 (en) Alarm system
AUPR807001A0 (en) Order system
AU2002322973A1 (en) Monitoring system
AU2002225575A1 (en) Monitoring system
AU2001275518A1 (en) Elimination-absorber monitoring system
AU2002307853A1 (en) Construction system
AU2002318524A1 (en) Arrangement for giving alarm
AU2001100040A4 (en) Tri-berl baiting system
AUPR708201A0 (en) Behaviour modification system
AUPR464301A0 (en) K9 - intruder alarm
AU2002318006A1 (en) Alarm
AU2002328004A1 (en) Alarm arrangement
HK1064073A (en) Condition monitoring system
AUPR483201A0 (en) Condition monitoring system
AU2002252829A1 (en) Condition monitoring system
AU2002244158A1 (en) Valve-pin position monitoring system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase